massarraytm assay design suite version 2.2 (agena bioscience)
90
Structured Review
agena bioscience
massarraytm assay design suite version 2.2
Massarraytm Assay Design Suite Version 2.2, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarraytm+system/massarraytm+assay+design+suite+version+2+2/pm39740751-95-8-15
Average 90 stars, based on 1 article reviews
Massarraytm Assay Design Suite Version 2.2, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarraytm+system/massarraytm+assay+design+suite+version+2+2/pm39740751-95-8-15
Average 90 stars, based on 1 article reviews
massarraytm assay design suite version 2.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Association of RFC G80A Polymorphism with Lung Cancer Susceptibility in a Hypertensive Population: A Nested Case-Control Study. Article Snippet: 1 Background: Polymorphisms of the folate-associated one-carbon metabolism (OCM) pathway 2 genes may regulate certain susceptibilities to cancer.. G80A, a polymorphism in the reduced folate 3 carrier (RFC) gene, may be associated with cancer risk, although the results obtained from previous 4 studies have been inconsistent.. 5 Objectives: The present study aimed to evaluate the association of G80A with lung cancer among a 6 Jo urn al Pr e-p roo f |